AfoliOpen Afoli →

Octreotide

Octreotide is an active ingredient of the class «hypothalamic hormones».

Open in Afoli Medicines →

Chemical compound

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

Sandostatin Injection is a somatostatin analogue indicated: Acromegaly: To reduce blood levels of growth hormone (GH) and insulin growth factor-1 (IGF-1; somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation…

US label

Oczyesa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.

EMA

How it works

Class: hypothalamic hormones

Common side effects

The following clinically significant adverse reactions are described elsewhere in the labeling: Complete Atrioventricular Block Cholelithiasis and Complications of Cholelithiasis Hyperglycemia and Hypoglycemia Thyroid Function Abnormalities Steatorrhea and Malabsorption of Dietary Fats Changes in Vitamin B12 Levels…

US label

Who should not take it

Sensitivity to this drug or any of its components. Sensitivity to this drug or any of its components.

US label

Pregnancy and breastfeeding

The limited data with Sandostatin Injection in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Bynfezia PEN · Mycapssa · Sandostatin · Sandostatin LAR

European Union

Oczyesa

Canada

Octreotide Acetate Omega · Octreotide Depot · Oczyesa XR · Sandostatin LAR

Other trade names

Octreotide acetate preservative free

Approval status

US Food and Drug Administration
prescription · since 1988
European Medicines Agency
authorised · since 2025
Health Canada
prescription · marketed
First approval anywhere
1988

Codes

ATC
H01CB02
RxNorm CUI
7617
ChEMBL
CHEMBL1680
PubChem CID
448601
UNII
RWM8CCW8GP
Wikidata
Q419935

Frequently asked questions

What is Octreotide used for?

Octreotide is used for: Carcinoid tumor, Neuroendocrine carcinoma, Pituitary carcinoma, Follicular adenoma, Acromegaly, Pancreatic cancer, Carcinoid syndrome, and Neoplasm.

What kind of medicine is Octreotide?

Octreotide is an active ingredient of the class «hypothalamic hormones».

What are the brand names of Octreotide?

Brand names of Octreotide include Bynfezia PEN, Mycapssa, Sandostatin, Sandostatin LAR, Oczyesa, Octreotide Acetate Omega, Octreotide Depot, and Oczyesa XR.

Sources and licences

Updated November 15, 2026